{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":8,"total":61,"mapped":6},"pagination":{"has_next":false},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"Q6YHU6","source":"Q6YHU6|tRNA (32-2'-O)-methyltransferase regulator THADA","targets":["5T6Y|HLA-B*57:01 presenting TSTFEDVKILAF|X-RAY DIFFRACTION|1.76|Homo sapiens; SYNTHETIC CONSTRUCT|0|IMMUNE SYSTEM","8Y2O|The Cryo-EM structure of human tRNA methyltransferase FTSJ1-THADA with substrate tRNA and S-adenosyl homocysteine (SAH)|ELECTRON MICROSCOPY|2.66|Homo sapiens; SYNTHETIC CONSTRUCT|0|RNA BINDING PROTEIN/RNA"]},{"input":"Q8TEH3","source":"Q8TEH3|DENN domain-containing protein 1A","targets":["6EKK|Crystal structure of GEF domain of DENND 1A in complex with Rab GTPase Rab35-GDP bound state.|X-RAY DIFFRACTION|1.82|Homo sapiens|0|TRANSCRIPTION"]},{"input":"P46937","source":"P46937|Transcriptional coactivator YAP1","targets":["1JMQ|YAP65 (L30K mutant) WW domain in Complex with GTPPPPYTVG peptide|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|STRUCTURAL PROTEIN","1K5R|YAP65 WW domain S24-Amino-Ethylsulfanyl-Acetic Acid mutant|SOLUTION NMR|||0|SIGNALING PROTEIN","1K9Q|YAP65 WW domain complexed to N-(n-octyl)-GPPPY-NH2|SOLUTION NMR|||0|STRUCTURAL PROTEIN","1K9R|YAP65 WW domain complexed to Acetyl-PLPPY|SOLUTION NMR|||0|STRUCTURAL PROTEIN","2LAW|Structure of the second WW domain from human YAP in complex with a human Smad1 derived peptide|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN/TRANSCRIPTION","2LAX|Structure of first WW domain of human YAP in complex with a human Smad1 doubly-phosphorilated derived peptide.|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN/TRANSCRIPTION","2LAY|Structure of the first WW domain of human YAP in complex with a phosphorylated human Smad1 derived peptide|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN/TRANSCRIPTION","2LTV|YAP WW2 in complex with a Smad7 derived peptide|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|PROTEIN BINDING/PEPTIDE","2LTW|YAP WW1 in complex with a Smad7 derived peptide|SOLUTION NMR||Homo sapiens; SYNTHETIC CONSTRUCT|0|PROTEIN BINDING/PEPTIDE","3KYS|Crystal structure of human YAP and TEAD complex|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSCRIPTION/PROTEIN BINDING","3MHR|14-3-3 sigma in complex with YAP pS127-peptide|X-RAY DIFFRACTION|1.15|Homo sapiens; SYNTHETIC CONSTRUCT|0|PEPTIDE BINDING PROTEIN","4RE1|Crystal structure of human TEAD1 and disulfide-engineered YAP|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSCRIPTION/PROTEIN BINDING","4REX|Crystal structure of the first WW domain of human YAP2 isoform|X-RAY DIFFRACTION|1.6|Homo sapiens|0|PROTEIN BINDING","5OAQ|TEAD4 COMPLEXED WITH YAP PEPTIDE AND MYRISTATE (COVALENTLY BOUND)|X-RAY DIFFRACTION|1.95|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","5YDX|NMR structure of YAP1-2 WW1 domain with LATS1 PPxY motif complex|SOLUTION NMR||Homo sapiens|0|SIGNALING PROTEIN","5YDY|NMR structure of YAP1-2 WW2 domain with LATS1 PPxY motif complex|SOLUTION NMR||Homo sapiens|0|SIGNALING PROTEIN","6G6X|14-3-3sigma in complex with a P129beta3P mutated YAP pS127 phosphopeptide|X-RAY DIFFRACTION|1.13|Homo sapiens; SYNTHETIC CONSTRUCT|0|ONCOPROTEIN","6G8I|14-3-3sigma in complex with a R124beta3R mutated YAP pS127 phosphopeptide|X-RAY DIFFRACTION|1.6|Homo sapiens; SYNTHETIC CONSTRUCT|0|ONCOPROTEIN","6G8J|14-3-3sigma in complex with a A130beta3A mutated YAP pS127 phosphopeptide|X-RAY DIFFRACTION|1.47|Homo sapiens; SYNTHETIC CONSTRUCT|0|ONCOPROTEIN","6G8K|14-3-3sigma in complex with a S131beta3S mutated YAP pS127 phosphopeptide|X-RAY DIFFRACTION|1.25|Homo sapiens; SYNTHETIC CONSTRUCT|0|ONCOPROTEIN","6G8L|14-3-3sigma in complex with a L132beta3L mutated YAP pS127 phosphopeptide|X-RAY DIFFRACTION|1.37|Homo sapiens; SYNTHETIC CONSTRUCT|0|ONCOPROTEIN","6G8P|14-3-3sigma in complex with a P129beta3P and L132beta3L mutated YAP pS127 phosphopeptide|X-RAY DIFFRACTION|1.9|Homo sapiens; SYNTHETIC CONSTRUCT|0|ONCOPROTEIN","6G8Q|14-3-3sigma in complex with a A130beta3A and Q133beta3Q mutated YAP pS127 phosphopeptide|X-RAY DIFFRACTION|1.85|Homo sapiens; SYNTHETIC CONSTRUCT|0|ONCOPROTEIN","6GE3|X-ray structure of TEAD4 (wildtype) complexed with YAP (wildtype): The role of residual flexibility and water molecules in the adaptation of a bound intrinsically disordered protein to mutations at a binding interface|X-RAY DIFFRACTION|1.85|Homo sapiens|0|TRANSCRIPTION","6GE4|TEAD4 (216-434);E263A COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 1.97A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA|X-RAY DIFFRACTION|1.97|Homo sapiens|0|TRANSCRIPTION","6GE5|TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.05A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA|X-RAY DIFFRACTION|2.05|Homo sapiens|0|TRANSCRIPTION","6GE6|X-ray structure of TEAD4(E263A+Y429F mutant) complexed with YAP(wildtype): The role of residual flexibility and water molecules in the adaptation of a bound intrinsically disordered protein to mutations at a binding interface|X-RAY DIFFRACTION|1.8|Homo sapiens|0|TRANSCRIPTION","6GEC|TEAD4 (216-434) COMPLEXED WITH YAP PEPTIDE (60-100);S94A AND MYRISTOATE (COVALENTLY BOUND) AT 1.70A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA|X-RAY DIFFRACTION|1.7|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","6GEE|TEAD4 (216-434);E263A COMPLEXED WITH YAP PEPTIDE (60-100); S94A AND MYRISTOATE (COVALENTLY BOUND) AT 1.96A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA|X-RAY DIFFRACTION|1.96|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","6GEG|TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100); S94A AND MYRISTOATE (COVALENTLY BOUND) AT 2.23A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA|X-RAY DIFFRACTION|2.23|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","6GEI|TEAD4 (216-434);E263A+Y429F COMPLEXED WITH YAP PEPTIDE (60- 100);S94A AND MYRISTOATE (COVALENTLY BOUND TO LYS344, NOT CYS367!) AT 1.65A (P41212 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA|X-RAY DIFFRACTION|1.65|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","6GEK|TEAD4 (216-434);Y429F COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.28A (P212121 CRYSTAL FORM); MYRISTOYLATION WAS DONE BY ADDING MYR-COA|X-RAY DIFFRACTION|2.28|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","6HIK|X-ray structure of TEAD4(Y429H) mutant) complexed with YAP (wildtype): Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy|X-RAY DIFFRACTION|1.65|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","6HIL|X-ray structure of TEAD1(Y421H mutant) complexed with YAP(wildtype): Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSCRIPTION","6Q2X|TEAD4 (216-434) COMPLEXED WITH YAP PEPTIDE (60-100) AND MYRISTOATE (COVALENTLY BOUND) AT 2.1A (P41212 CRYSTAL FORM)|X-RAY DIFFRACTION|2.1|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","7O07|14-3-3sigma covalently bound to peptide (chloroacetamide-Cys interaction)|X-RAY DIFFRACTION|1.2|Homo sapiens; SYNTHETIC CONSTRUCT|0|PEPTIDE BINDING PROTEIN","8A8Q|Crystal structure of Protein Scalloped in complex with YAP peptide|X-RAY DIFFRACTION|1.465|Drosophila melanogaster; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","8A8R|Crystal structure of TEAD4 in complex with YAP peptide|X-RAY DIFFRACTION|1.696|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION","8C2F|Structure of 14-3-3 sigma delta C with electrophilic peptide 3MHR-5|X-RAY DIFFRACTION|2.3|Homo sapiens; SYNTHETIC CONSTRUCT|0|PROTEIN BINDING","8WRG|Solution structure of the TAD domain (450-504) of human transcriptional coactivator YAP1|SOLUTION NMR||Homo sapiens|0|TRANSCRIPTION","9FZA|TEAD1/YAP in complex with a reversible inhibitor N-[(4-phenoxyphenyl)methyl]imidazo[1,2-a]pyridine-3-carboxamide|X-RAY DIFFRACTION|2.214|Homo sapiens|0|TRANSCRIPTION"]},{"input":"P43694","source":"P43694|Transcription factor GATA-4","targets":["2M9W|Solution NMR Structure of Transcription Factor GATA-4 from Homo sapiens, Northeast Structural Genomics Consortium (NESG) Target HR4783B|SOLUTION NMR||Homo sapiens|0|TRANSCRIPTION","8VG0|Cryo-EM structure of GATA4 in complex with ALBN1 nucleosome|ELECTRON MICROSCOPY|3.07|Homo sapiens; SYNTHETIC CONSTRUCT|0|NUCLEAR PROTEIN/DNA","8VG1|Cryo-EM structure of FoxA1 and GATA4 in complex with ALBN1 nucleosome|ELECTRON MICROSCOPY|2.48|Homo sapiens; SYNTHETIC CONSTRUCT|0|NUCLEAR PROTEIN/DNA"]},{"input":"Q05516","source":"Q05516|Zinc finger and BTB domain-containing protein 16","targets":["1BUO|BTB DOMAIN FROM PLZF|X-RAY DIFFRACTION|1.9|Homo sapiens|0|GENE REGULATION","1CS3|STRUCTURE OF BTB/POZ TRANSCRIPTION REPRESSION DOMAIN FROM PROMELOCYTIC LEUKEMIA ZINC FINGER ONCOPROTEIN|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSCRIPTION","8YTH|Crystal structures of human IRF2BP2 RING domain in complex with ZBTB16 peptide|X-RAY DIFFRACTION|2.4|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSCRIPTION"]},{"input":"Q9GZV5","source":"Q9GZV5|WW domain-containing transcription regulator protein 1","targets":["5N5R|14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV1|X-RAY DIFFRACTION|1.801|Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN","5N5T|14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV2|X-RAY DIFFRACTION|1.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|PROTEIN BINDING","5N5W|14-3-3 sigma in complex with TAZ pS89 peptide and fragment NV3|X-RAY DIFFRACTION|1.37|Homo sapiens; SYNTHETIC CONSTRUCT|0|PROTEIN BINDING","5N75|14-3-3 sigma in complex with TAZ pS89 peptide|X-RAY DIFFRACTION|1.803|Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN","6RHC|Fragment AZ-003 binding at the TAZpS89/14-3-3 sigma interface|X-RAY DIFFRACTION|1.2|Homo sapiens; SYNTHETIC CONSTRUCT|0|PEPTIDE BINDING PROTEIN","6RJL|Fragment AZ-018 binding at the TAZpS89/14-3-3 sigma interface|X-RAY DIFFRACTION|1.28|Homo sapiens; SYNTHETIC CONSTRUCT|0|PEPTIDE BINDING PROTEIN","6RJQ|Fragment AZ-006 binding at the TAZpS89/14-3-3 sigma interface|X-RAY DIFFRACTION|1.885|Homo sapiens; SYNTHETIC CONSTRUCT|0|PEPTIDE BINDING PROTEIN","6RP6|Fragment AZ-019 binding at the TAZpS89/14-3-3 sigma interface|X-RAY DIFFRACTION|1.885|Homo sapiens; SYNTHETIC CONSTRUCT|0|PEPTIDE BINDING PROTEIN","6SLW|Fragment AZ-004 binding at the TAZpS89/14-3-3 sigma interface|X-RAY DIFFRACTION|2|Homo sapiens; SYNTHETIC CONSTRUCT|0|PEPTIDE BINDING PROTEIN","6SLX|Fragment AZ-010 binding at the TAZpS89/14-3-3 sigma interface|X-RAY DIFFRACTION|1.80005|Homo sapiens; SYNTHETIC CONSTRUCT|0|PEPTIDE BINDING PROTEIN","8R0Z|14-3-3 sigma in complex with TAZ peptide and stabilizing fragment TCF199|X-RAY DIFFRACTION|1.2|Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN"]}],"not_found":["P52926","P10914"]}